Non-potassium sparing diuretics can have ECG changes and hypokalemia acutely worsened by beta-agonists, especially at exceeded doses. Caution advised in co-administration.
Source: NLP:albuterol sulfate
11 interactions on record
Non-potassium sparing diuretics can have ECG changes and hypokalemia acutely worsened by beta-agonists, especially at exceeded doses. Caution advised in co-administration.
Source: NLP:albuterol sulfate
Non-potassium sparing diuretics may cause ECG changes and hypokalemia that can be worsened by beta-agonists. Use with caution.
Source: NLP:arformoterol tartrate
Increased risk of hypokalemia with coadministration of dichlorphenamide and loop diuretics.
Source: NLP:dichlorphenamide
Low-dose dopamine with diuretics may produce additive or potentiating effect on urine flow.
Source: NLP:dopamine hydrochloride
Loop diuretics should be avoided; thiazides are recommended instead as loop diuretics inhibit renal tubular secretion of foscarnet.
Source: NLP:foscarnet sodium
Non-potassium sparing diuretics can worsen ECG changes and hypokalemia induced by β-agonists, especially at higher doses.
Source: NLP:ipratropium bromide and albuterol sulfate
May worsen ECG changes or hypokalemia. Monitor potassium levels during coadministration.
Source: NLP:levalbuterol
NSAIDs can reduce natriuretic effect of loop diuretics. Monitor diuretic efficacy including antihypertensive effects.
Source: NLP:sumatriptan and naproxen sodium
Nonpotassium-sparing diuretics may cause ECG changes and hypokalemia that can be worsened by beta-agonists, especially at higher doses.
Source: NLP:terbutaline sulfate
May worsen electrocardiographic changes and/or hypokalemia associated with non-potassium-sparing diuretics when combined with beta-agonists. Use with caution.
Source: NLP:umeclidinium bromide and vilanterol trifenatate
Concomitant use with zoledronic acid may increase risk of hypocalcemia. Caution should be exercised when zoledronic acid is used in combination with loop diuretics.
Source: NLP:zoledronic acid